Key Trends in 2018 in the Biopharmaceutical Market
Interview with Nigel Darby, Advisor, GE Healthcare Life Sciences
The Challenge of Immunotherapy: Staying on Target
Immunotherapies Can Produce Side Effects That Mimic Autoimmune Diseases
Toward a Universal Flu Vaccine
New Candidate Fights Back against the Flu’s Efforts to Undermine the Human Immune System
Top 10 Best-Selling Cancer Drugs, Q1–Q3 2017
15% Year-Over-Year Growth, with Sales Set to More than Double by 2022
For full access to this article login to GEN Select now.
NGS Systems Secure Place in Clinic
- Next-gen sequencing (NGS), the media-friendly moniker for automated massively parallel DNA or RNA sequencing technology, has made the leap from a powerhouse tool for molecular biology research and drug discovery and development to the clinical arena. Not an easy feat for a complex, expensive technology that generates huge ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.